Patent directory · USPTO A61K / A61P
Patents matching “The Regents of the University of California”
3,494 pharma patents match "The Regents of the University of California" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 3,494 pharmaceutical patents matching "The Regents of the University of California" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 9089531
GABA agonists in the treatment of disorders associated with metabolic syndrome and GABA combinations in treatment or prophylaxis of type I diabetes
granted -
US 9084762
T-cell immunogens derived from anti-viral proteins and methods of using same
granted -
US 9084782
Chemical inhibitors of cholesterol biosynthesis and venous angiogenesis
granted -
US 9085644
Mutations in the Bcr-Abl tyrosine kinase associated with resistance to STI-571
granted -
US 9078881
Salinosporamides and methods of use thereof
granted -
US 9078922
Metal-organic frameworks with exceptionally large pore aperatures
granted -
US 9080148
Neuronal cells cultured on microparticles and methods of using the neuronal cells
granted -
US 9073884
Anti-inflammatory and quorum sensing inhibition compounds and methods of making and using them
granted -
US 9072792
Peptides whose uptake by cells is controllable
granted -
US 9072732
Indication for use of niacin (nicotinic acid) for treatment and reversal of fatty liver disease
granted -
US 9073863
Cyanoquinoline compounds having activity in correcting mutant-CFTR processing and increasing ion transport and uses thereof
granted -
US 9073974
RGD-containing cyclic peptides
granted -
US 9073980
Tumor selective E1a and E1b mutants
granted -
US 9066900
Interferon-β production modulating listeria strains and methods for using same
granted -
US 9066855
Controlled release auris sensory cell modulator compositions and methods for the treatment of otic disorders
granted -
US 9061071
Analogs of ShK toxin and their uses in selective inhibition of Kv1.3 potassium channels
granted -
US 9061048
Cyclic di-AMP induction of type I interferon
granted -
US 9063125
Compositions comprising cells expressing cold- and menthol-sensitive receptor (CMR1) polypeptides
granted -
US 9056102
VEGF-activated trail ligands
granted -
US 9056924
Mutations in the BCR-ABL tyrosine kinase associated with resistance to STI-571
granted -
US 9050298
Method of treating ischemia/reperfusion injuries to a heart with netrin-1
granted -
US 9050376
Conjugates of synthetic TLR agonists and uses therefor
granted -
US 9050299
Administration of growth factors for the treatment of CNS disorders
granted -
US 9045474
Compounds and compositions for mitigating tissue damage and lethality
granted